Werewolf Therapeutics, Inc. (HOWL)
NASDAQ: HOWL · Real-Time Price · USD
0.9517
-0.0446 (-4.48%)
At close: Dec 5, 2025, 4:00 PM EST
0.9559
+0.0042 (0.44%)
After-hours: Dec 5, 2025, 7:48 PM EST
Werewolf Therapeutics Market Cap
Werewolf Therapeutics has a market cap or net worth of $46.20 million as of December 5, 2025. Its market cap has decreased by -39.38% in one year.
Market Cap
46.20M
Enterprise Value
17.78M
1-Year Change
-39.38%
Ranking
Category
Stock Price
$0.95
Market Cap Chart
Since the IPO on April 30, 2021, Werewolf Therapeutics's market cap has decreased from $440.42M to $46.20M, a decrease of -89.51%. That is a compound annual growth rate of -38.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 48.36M | -26.67% |
| Dec 31, 2024 | 65.95M | -52.79% |
| Dec 29, 2023 | 139.70M | 121.66% |
| Dec 30, 2022 | 63.03M | -80.81% |
| Dec 31, 2021 | 328.47M | -25.42% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |